Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mech Dev ; 154: 179-192, 2018 12.
Article in English | MEDLINE | ID: mdl-30059773

ABSTRACT

Organogenesis is one of the most striking process during development. During this period, organ primordia pass throughout several stages in which the level of organisation increases in complexity to achieve the final organ architecture. Organ culture, a method in which an isolated organ is explanted and maintained ex-vivo, is an excellent tool for following the morphological dynamics during development. While most of the work has been made in early stages of development, culturing organs in mid-late stages is needed to understand the achievement of the final organ anatomy in the new-born. Here, we investigated the possibility of following morphological changes of the mice heart, lung, kidney and intestine using a filter-grid culture method for 7 days starting at E14.5. We observed that the anatomy, histology and survival of the cultured organs were indicative of a continuity of the developmental processes: they survived and morphodifferentiated during 5-7 days in culture. The exception was the heart, which started to die after 4 days. Using a second approach, we demonstrated that heart tissue can be easily cultured in body slices, together with other tissues such as the lung, with a healthier differentiation and longer survival. The culture method used here, permits a high-resolution imaging to identify the dynamic of organ architecture ex-vivo using morphovideos. We also confirmed the suitability of this system to perform lineage tracing using a vital dye in branching organs. In summary, this work tested the feasibility of monitoring and recording the anatomical changes that establish the final organ structure of the heart, lung, kidney and intestine. Additionally, this strategy allows the morphological study of organ development including fate maps with a relative long-term survival up to the onset of differentiation. This work contributes to elucidating how organs are formed, promoting the understanding of congenital malformations and to design organ replacement therapies.


Subject(s)
Morphogenesis/physiology , Organogenesis/physiology , Animals , Cell Differentiation/physiology , Heart/growth & development , Kidney/growth & development , Lung/growth & development , Mice , Mice, Inbred C57BL , Organ Culture Techniques/methods
2.
Toxicol In Vitro ; 24(6): 1532-7, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20624455

ABSTRACT

Cadmium is a toxicant with known carcinogenic and endocrine disruptor effects. We have previously reported that prenatal exposure to cadmium may induce low birth weight which is associated to increased foetal exposure to glucocorticoids; both signals constitute "hallmarks" of developmental programming. Since the effect of cadmium on the glucocorticoid system of placental carcinogenic cells is unknown, in the present work, we studied the effect of acute low dose of cadmium on cortisol production and 11beta-HSD2 expression and activity by cultured human choriocarcinoma cells (JEG-3). In addition, it was also evaluated whether those effects were related to the methylation index of the HSD11B2 gene, which can be regulated by epigenetic mechanisms. Cells were incubated with low cadmium dose (0.5 and 1 microM) for 24h and viability (MTT), cortisol production (EIA), 11beta-HSD2 expression (qRT-PCR) and activity (radioassay), and methylation index of the HSD11B2 gene were determined. Results show lower cortisol concentrations in the incubation media of exposed cells, which were associated to increased 11beta-HSD2 expression and activity and to a lower methylation index of the gene. These results suggest that cadmium-induced endocrine disruptor effects on JEG-3 cells could be mediated by changes in the methylation status of some target genes.


Subject(s)
11-beta-Hydroxysteroid Dehydrogenase Type 2/metabolism , Cadmium Compounds/toxicity , Choriocarcinoma/drug therapy , Environmental Pollutants/toxicity , Hydrocortisone/metabolism , 11-beta-Hydroxysteroid Dehydrogenase Type 2/genetics , Cell Line, Tumor , Cell Survival/drug effects , Choriocarcinoma/metabolism , DNA Methylation/drug effects , Gene Expression/drug effects , Gene Silencing/drug effects , Humans , RNA, Messenger/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...